1. Home
  2. ARQT vs PPLI Comparison

ARQT vs PPLI Comparison

Compare ARQT & PPLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

SELL

Current Price

$27.14

Market Cap

3.3B

Sector

Health Care

ML Signal

SELL

Logo People Incorporated Common Stock

PPLI

People Incorporated Common Stock

SELL

Current Price

$43.28

Market Cap

2.7B

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
ARQT
PPLI
Founded
2016
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.7B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
ARQT
PPLI
Price
$27.14
$43.28
Analyst Decision
Buy
Buy
Analyst Count
8
11
Target Price
$40.38
★ $50.80
AVG Volume (30 Days)
★ 2.4M
1.1M
Earning Date
11-04-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 88.79
79.97
EPS
★ 0.09
N/A
Revenue
$376,072,000.00
★ $4,365,235,000.00
Revenue This Year
$44.19
N/A
Revenue Next Year
$29.31
$0.11
P/E Ratio
$314.67
★ N/A
Revenue Growth
★ 91.34
N/A
52 Week Low
$19.30
$34.79
52 Week High
$34.80
$48.32

Technical Indicators

Market Signals
Indicator
ARQT
PPLI
Relative Strength Index (RSI) 44.15 61.22
Support Level $25.08 $40.37
Resistance Level $28.54 $47.96
Average True Range (ATR) 1.58 1.71
MACD -0.48 0.54
Stochastic Oscillator 19.64 86.85

Price Performance

Historical Comparison
ARQT
PPLI

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

About PPLI People Incorporated Common Stock

People Inc is a media and publishing business that operates a portfolio of brands, including PEOPLE, Food & Wine, Travel + Leisure, InStyle, Better Homes & Gardens, and Southern Living. The company also holds a minority equity stake in MGM Resorts International.

Share on Social Networks: